Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps increase insulin sensitivity, decrease glucagon production, delay gastric emptying, and increase fat metabolism, resulting in weight loss. Average weight loss with semaglutide is up to 14.9% of body weight in 72 weeks.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps increase insulin sensitivity, decrease glucagon production, delay gastric emptying, and increase fat metabolism, resulting in weight loss. Average weight loss with semaglutide is up to 14.9% of body weight in 72 weeks.